Menu
Recruiting NCT06754215

Smoking Cessation Intervention Development for Homeless Youth

No phase Interventional Cigarette Smoking-Related Carcinoma

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Focus Group, Interview, Smoking Cessation Intervention, Survey Administration.
Who it may be relevant to
Registry conditions: Cigarette Smoking-Related Carcinoma. Basic parameters: 14 years — 24 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Development of a Contextually Tailored and Optimized Smoking Cessation Intervention for Homeless Youth

Overview

This trial develops a contextually tailored and optimized smoking cessation intervention and studies smoking motivations and motivations to quit smoking in homeless youth. Identifying motivations for smoking and motivations to quit smoking may help researchers build a program to help homeless young people quit smoking cigarettes if desired.

Detailed description

PRIMARY OBJECTIVES:

I. Establish a theoretical framework for cessation among homeless youth incorporating phase-specific capabilities and opportunities impacting motivation to engage in cessation. (Multiphase Optimization STrategy \[MOST\] Step 1) II. Guided by the theoretical framework for cessation among homeless youth, identify a set of cessation intervention components and assess their implementation feasibility. (MOST Step 2)

OUTLINE:

MOST STEP Ia: Participants attend a semi-structured interview over 60 minutes to help establish theoretical model of contextually tailored smoking cessation for homeless youth.

MOST STEP Ib: Participants complete a survey to help establish theoretical model of contextually tailored smoking cessation for homeless youth.

MOST STEP II (FOCUS GROUPS): Participants attend focus groups to help identify a set of cessation intervention components for homeless youth and determine component acceptability and feasibility.

MOST STEP II (FEASIBILITY STUDY): Intervention components are identified and selected from Focus Groups. Participants take part in a study to assess these components for feasibility in implementing in coordination with homeless youth services, as well as determining main effect estimates for future studies.

Interventions

  • Behavioral Focus Group
    Participate in focus group
  • Other Interview
    Participate in semi-structured interview
  • Behavioral Smoking Cessation Intervention
    Participate in feasibility study of intervention components
  • Other Survey Administration
    Complete survey

Primary outcome measures

  • Youth's psychological and physical capacity (capability) [Time frame: Up to 3 years]
  • Youth's physical and social factors (opportunity) [Time frame: Up to 3 years]

Eligibility criteria

Inclusion criteria

  • Youth who report having smoked some or every day in the past week.
  • Youth who meet criteria for homelessness defined by the 2002 McKinney-Vento Act including those who lack a fixed, regular, and adequate nighttime residence; live in a welfare hotel, or place without regular sleeping accommodations; or live in a shared residence with other persons due to the loss of one's housing or economic hardship.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Non-randomized
Model
Sequential
Masking
Open label
Primary purpose
Prevention

Study locations

United States · 1 center
  • Ohio State University Comprehensive Cancer Center — Columbus

Identifiers

NCT: NCT06754215 · OSU-17281 · NCI-2019-02248 · K07CA216321

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗